UPDATE 1-Chindex posts lower Q2 profit, shares sink

* Q2 profit falls to $0.03/shr

* Q2 revenue flat at $38.1 mln

* Q2 hurt by review of import approvals in China

* Shares down as much as 28 pct

Nov 9 (Reuters) - Chindex International Inc (CHDX.O: Quote, Profile, Research), a provider of western healthcare products and services in China, posted a 38 percent drop in quarterly profit, hurt by a review of import approvals by the Chinese government, sending its shares down as much as 28 percent.

The company supplies medical equipment to China from several companies including Intuitive Surgical Inc (ISRG.O: Quote, Profile, Research), the maker of the da Vinci surgical robots.

The company said the Chinese government's review, a routine process, is impacting new, big ticket medical products.

Revenue from the medical products division fell 10 percent to $17.1 million due to delays in the order cycle for high-value capital medical equipment, particularly robotic surgical systems.

However, it said expectations for the order flow for da Vinci's has not changed and it continues to expect sales of one to two systems per quarter on average, over time.